Author

TI Andersen

Institutions: Oslo University Hospital, Haukeland University Hospital

Observed institutions: Oslo University Hospital, Institute of Cancer Research, University of Oslo, Haukeland University Hospital

OpenAlex ID: A5087907334

Prognostic significance of TP53 alterations in breast carcinoma

1993 · TI Andersen, R Holm, et al. · British Journal of Cancer · 162

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis

1990 · A-L Børresen, L Ottestad, et al. · British Journal of Cancer · 59

Genome scanning of breast cancers by two-dimensional DNA typing

1994 · AM Verwest, WJF de Leeuw, et al. · British Journal of Cancer · 15

Correction: Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: Relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (Pharmacogenetics, 8, 5 (441-447))

1999 · Vessela N. Kristensen, TI Andersen, et al. · Pharmacogenetics · 1

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

2000 · P Kringen, HG Eiken, et al. · Breast Cancer Research

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

2000 · A Langerød, TI Andersen, et al. · Breast Cancer Research

Screening breast cancer patients for Norwegian ATM mutations

2000 · K Laake, P Vu, et al. · Breast Cancer Research

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

2000 · TI Andersen, E Skovlund, et al. · Breast Cancer Research

Works count: 8

Citation count: 237

H-index: 3

I10-index: 3